Adherium receives $1.5m Australian R&D Tax Rebate
Filed with ASX · · 1 page · English
Earlier from Adherium
- New CEO Appointed - Dr Paul Mastoridis
- Resignation of CEO
- Notice of Annual General Meeting/Proxy Form
- Annual Report to shareholders
- Adherium SPP and Shortfall Offers Prospectus
Later from Adherium
- First Patient Enrolled in Major e-health Clinical Study
- Placement and Entitlement Offer to raise up to $8.37 million
- Non-Renounceable Rights Issue Offer Completes
- AstraZeneca selected Adherium Smartinhaler for its study
- Management Change
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium